These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33757389)

  • 1. Efficacy of Analytical Technologies in Metabolomics Studies of the Gastrointestinal Cancers.
    Aftabi Y; Soleymani J; Jouyban A
    Crit Rev Anal Chem; 2022; 52(7):1593-1605. PubMed ID: 33757389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics profile in gastrointestinal cancers: Update and future perspectives.
    Nannini G; Meoni G; Amedei A; Tenori L
    World J Gastroenterol; 2020 May; 26(20):2514-2532. PubMed ID: 32523308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.
    Abooshahab R; Gholami M; Sanoie M; Azizi F; Hedayati M
    Endocrine; 2019 Jul; 65(1):1-14. PubMed ID: 30937722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
    Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
    Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics Toward Biomarker Discovery.
    Yin P; Xu G
    Methods Mol Biol; 2017; 1619():467-475. PubMed ID: 28674904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
    Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
    Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput metabolomics for discovering metabolic biomarkers from intestinal tumorigenesis in APC
    Guo XD; Liu L; Xiao HY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov; 1100-1101():131-139. PubMed ID: 30316137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics of lung cancer: Analytical platforms and their applications.
    Noreldeen HAA; Liu X; Xu G
    J Sep Sci; 2020 Jan; 43(1):120-133. PubMed ID: 31747121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q; Wang C; Li B
    Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat Fecal Metabolomics-Based Analysis.
    Deda O; Gika HG; Theodoridis GA
    Methods Mol Biol; 2018; 1738():149-157. PubMed ID: 29654588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
    Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current metabolomics: technological advances.
    Putri SP; Yamamoto S; Tsugawa H; Fukusaki E
    J Biosci Bioeng; 2013 Jul; 116(1):9-16. PubMed ID: 23466298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in Alzheimer's disease: The need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology.
    González-Domínguez R; Sayago A; Fernández-Recamales Á
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1071():75-92. PubMed ID: 28189423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplatform analytical methodology for metabolic fingerprinting of lung tissue.
    Naz S; García A; Barbas C
    Anal Chem; 2013 Nov; 85(22):10941-8. PubMed ID: 24144172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics in the natural products field--a gateway to novel antibiotics.
    Wu C; Kim HK; van Wezel GP; Choi YH
    Drug Discov Today Technol; 2015 Jun; 13():11-7. PubMed ID: 26190678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics of neural progenitor cells: a novel approach to biomarker discovery.
    Maletić-Savatić M; Vingara LK; Manganas LN; Li Y; Zhang S; Sierra A; Hazel R; Smith D; Wagshul ME; Henn F; Krupp L; Enikolopov G; Benveniste H; Djurić PM; Pelczer I
    Cold Spring Harb Symp Quant Biol; 2008; 73():389-401. PubMed ID: 19022759
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.